Syndax Pharmaceuticals
SNDX
SNDX
63 hedge funds and large institutions have $160M invested in Syndax Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.73% more ownership
Funds ownership: 61.15% → 63.89% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
63
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$19.6M | |
| 2 | +$3.37M | |
| 3 | +$3.27M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$2.74M |
| 5 |
Millennium Management
New York
|
+$2.71M |
Top Sellers
| 1 | -$3.74M | |
| 2 | -$3.27M | |
| 3 | -$3.15M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$722K |
| 5 |
Jennison Associates
New York
|
-$672K |